Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
3 "Body mass index"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
IBD
Predictors of histologic remission in patients with biologic-naïve, moderate-to-severe ulcerative colitis treated with first-line biologic agents and small-molecule drugs: a single-center, retrospective cohort study
Kijae Jo, Kwang Woo Kim, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim, Seong-Joon Koh
Intest Res 2024;22(4):453-463.   Published online May 22, 2024
DOI: https://doi.org/10.5217/ir.2024.00044
AbstractAbstract PDFPubReaderePub
Background/Aims
The prevalence and incidence of ulcerative colitis (UC) in Korea is increasing. Each patient has a different disease course and treatment response. Recently, with the development of biologic agents, histological remission has become a treatment goal. In this study, we aimed to identify the predictors of histological remission after first-line biologic agent treatment in patients with biologic agent-naïve UC.
Methods
We retrospectively analyzed the medical records of 92 patients who had been diagnosed with UC and treated with first-line biologic agent treatment at our center, between 2015 and 2022. The clinical characteristics, laboratory test results, and endoscopic and biopsy findings were analyzed. Histological remission was defined as the absence of cryptitis, crypt abscesses, and inflammatory cells on histology. Univariate and multivariate logistic regression analyses were performed to identify the predictors of histological remission after first-line treatment.
Results
Of the total 92 patients, 25 (27.2%) achieved histological remission. Each cohort had a varied body mass index (BMI) distribution, with a statistically significant overweight ratio, as defined by the Asian-Pacific BMI category of 23–25 kg/m2, of 48.0% in the histological remission cohort (P= 0.026). A causal correlation between the overweight category and histological remission was confirmed (odds ratio, 3.883; 95% confidence interval, 1.141–13.212; P= 0.030).
Conclusions
We confirmed that the overweight category was a predictor of histological remission after first-line treatment with a biological agent. However, as BMI does not account for skeletal muscle mass, future studies are required to confirm the correlation between skeletal muscle mass and histological remission.
  • 5,449 View
  • 211 Download
Close layer
Miscellaneous
Patients with celiac disease are at high risk of developing metabolic syndrome and fatty liver
Ashish Agarwal, Alka Singh, Wajiha Mehtab, Vipin Gupta, Ashish Chauhan, Mahendra Singh Rajput, Namrata Singh, Vineet Ahuja, Govind K. Makharia
Intest Res 2021;19(1):106-114.   Published online April 22, 2020
DOI: https://doi.org/10.5217/ir.2019.00136
AbstractAbstract PDFPubReaderePub
Background/Aims
Gluten-free diet has an excess of fats and simple sugars and puts patients with celiac disease at risk of metabolic complications including metabolic syndrome and fatty liver. We assessed prevalence of metabolic syndrome and fatty liver in two cohorts of celiac disease.
Methods
Study was done in 2 groups. In group 1, 54 treatment naïve patients with celiac disease were recruited. Of them, 44 returned after 1-year of gluten-free diet and were reassessed. In group 2, 130 celiac disease patients on gluten-free diet for ≥1 year were recruited. All patients were assessed for anthropometric and metabolic parameters and fatty liver. Metabolic syndrome was defined as per consensus definition for Asian Indians. Fatty liver was defined as controlled attenuation parameter value >263 decibels by FibroScan.
Results
In group 1, of 44 treatment naïve patients with celiac disease, metabolic syndrome was present in 5 patients (11.4%) at baseline and 9 (18.2%) after 1 year of gluten-free diet. Patients having fatty liver increased from 6 patients (14.3%) at baseline to 13 (29.5%) after 1year of gluten-free diet (P=0.002). In group 2, of 130 patients with celiac disease on gluten-free diet for a median duration of 4 years, 30 out of 114 (26.3%) and 30 out of 130 patients (23%) had metabolic syndrome and fatty liver, respectively.
Conclusions
Patients with celiac disease are at high risk of developing metabolic syndrome and fatty liver, which increases further with gluten-free diet. These patients should be assessed for nutritional and metabolic features and counseled about balanced diet and physical activity regularly.

Citations

Citations to this article as recorded by  
  • Comprehensive LC-ESI-HRMS/MS Profiling and Assessment of Texture, Predicted Glycaemic Index, Antioxidant Activity and Digestive Enzyme Inhibition of Gluten- and Lactose-Free Cookies Enriched with Pomegranate By-Products
    Roberta Pino, Rosa Tundis, Vincenzo Sicari, Antonio Mincione, Antonio Gattuso, Chiara La Torre, Alessia Fazio, Sonia Piacente, Milena Masullo, Antonietta Cerulli, Monica Rosa Loizzo
    Foods.2026; 15(3): 457.     CrossRef
  • Dietary assessments in individuals living with coeliac disease: key considerations
    Anne R. Lee, Melinda Dennis, Jessica Lebovits, Lori Welstead, Ritu Verma, Amelie Therrien, Benjamin Lebwohl
    Journal of Human Nutrition and Dietetics.2025;[Epub]     CrossRef
  • Exploring the link between celiac disease and obesity: a potential role of gut microbiome
    Sunaina Addanki, Anastasia Mashukova, Arkene Levy
    Intestinal Research.2025; 23(2): 193.     CrossRef
  • Raman Hyperspectroscopy and Chemometric Analysis of Blood Serum for Diagnosing Celiac Disease in Adults
    Entesar Al-Hetlani, Lamyaa M. Almehmadi, Igor K. Lednev
    Photonics.2025; 12(6): 553.     CrossRef
  • The Gluten-Free Diet for Celiac Disease
    Kendra Weekley, David Gardinier, Anne R. Lee, Vanessa Weisbrod
    Gastrointestinal Endoscopy Clinics of North America.2025; 35(4): 753.     CrossRef
  • Towards personalized microbial therapies for metabolic alterations in celiac disease
    Alejandro Borrego-Ruiz, Juan J. Borrego
    Exploration of Digestive Diseases.2025;[Epub]     CrossRef
  • Effects of gluten-free diet on metabolic syndrome components and anthropometric indices in patients with nonalcoholic fatty liver disease: An open-label randomized clinical trial
    Maziar Jazayeri, Rasoul Zarrin, Afshin Mohammadi, Mohammad Reza Pashaei, Sajjad Ahmadpour
    Arab Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Hepatic Steatosis and Diet in Adult Celiac Disease: A Cross-Sectional Study
    Míra Zsófia Peresztegi, Zsolt Szakács, Nelli Farkas, Gábor Szekeres, Nándor Faluhelyi, Krisztina Hagymási, Gyula Pásztor, Zsófia Vereczkei, Petra Fülöp, Szilvia Lada, Sarolta Dakó, Eszter Dakó, Judit Bajor
    Nutrients.2025; 17(22): 3577.     CrossRef
  • Celiac Disease as a Model of Intestinal Malnutrition: Mechanisms and Nutritional Management
    Vanessa Nadia Dargenio, Nicoletta Sgarro, Giovanni La Grasta, Martina Begucci, Stefania Paola Castellaneta, Costantino Dargenio, Leonardo Paulucci, Ruggiero Francavilla, Fernanda Cristofori
    Nutrients.2025; 17(23): 3741.     CrossRef
  • Correlations Between Obesity and Autoimmune Diseases
    Anatoly I. Khavkin, Valeriya P. Novikova, Andrew V. Nalyotov, Ludmila A. Podorova, Marina Yu. Komissarova, Dmitry I. Masyuta
    Pediatric pharmacology.2025; 22(5): 624.     CrossRef
  • Efficacy of Antiobesity Medications in Patients With Celiac Disease on a Gluten-free Diet
    Diego Anazco, Sima Fansa, Wissam Ghusn, Khushboo Gala, Bryan Nicolalde, Elif Tama, Gerardo Calderon, Adam C. Bledsoe, Maria D. Hurtado, Joseph A. Murray, Andres Acosta
    Journal of Clinical Gastroenterology.2024; 58(7): 650.     CrossRef
  • Guidelines for best practices in monitoring established coeliac disease in adult patients
    Luca Elli, Daniel Leffler, Christophe Cellier, Benjamin Lebwohl, Carolina Ciacci, Michael Schumann, Knut E. A. Lundin, Stefania Chetcuti Zammit, Reena Sidhu, Leda Roncoroni, Julio C. Bai, Anne R. Lee, Melinda Dennis, Marie E. Robert, Kamran Rostami, Sheri
    Nature Reviews Gastroenterology & Hepatology.2024; 21(3): 198.     CrossRef
  • Probiotic Interventions in Coeliac Disease: A Systematic Review with a Focus on Cardiovascular Risk
    Lorretta Olu Fagbemi, Carlo Soldaini, Adele Costabile, Sofia Kolida, Carolina Ciacci, Yvonne Jeanes
    Gastrointestinal Disorders.2024; 6(1): 114.     CrossRef
  • Metabolomics and lipidomics signature in celiac disease: a narrative review
    Mohammad Rostami-Nejad, Nastaran Asri, Sajjad Bakhtiari, Ensieh Khalkhal, Sepehr Maleki, Mostafa Rezaei-Tavirani, Somayeh Jahani-Sherafat, Kamran Rostami
    Clinical and Experimental Medicine.2024;[Epub]     CrossRef
  • Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study
    Shuai Yuan, Dan Leffler, Benjamin Lebwohl, Peter H. R. Green, Jiangwei Sun, Sofia Carlsson, Susanna C. Larsson, Jonas F. Ludvigsson
    Diabetologia.2024; 67(8): 1630.     CrossRef
  • Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease
    Hye Kyung Hyun, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon
    European Journal of Gastroenterology & Hepatology.2024; 36(4): 445.     CrossRef
  • The Impact of a Gluten-Free Diet on Pregnant Women with Celiac Disease: Do We Need a Guideline to Manage Their Health?
    Yeliz Serin, Camilla Manini, Pasqualino Amato, Anil K. Verma
    Gastrointestinal Disorders.2024; 6(3): 675.     CrossRef
  • The Effects of Gluten-free Diet on Body Mass Indexes in Adults with Celiac Disease
    Noam Peleg, Yaron Niv, Ram Dickman, Doron Boltin, Alex Krauthammer, Michal Herman-Edelstein, Nidal Issa, Jacob E. Ollech, Tom Konikoff, Rachel Gingold-Belfer
    Journal of Clinical Gastroenterology.2024; 58(10): 989.     CrossRef
  • Nutrition Assessment and Management in Celiac Disease
    M. Ines Pinto-Sanchez, Jedid-Jah Blom, Peter R. Gibson, David Armstrong
    Gastroenterology.2024;[Epub]     CrossRef
  • Celiac disease - a pluripathological model in pediatric practice
    Vasile Valeriu Lupu, Maria Oana Sasaran, Elena Jechel, Iuliana Magdalena Starcea, Ileana Ioniuc, Adriana Mocanu, Solange Tamara Rosu, Valentin Munteanu, Alin Horatiu Nedelcu, Ciprian Danielescu, Delia Lidia Salaru, Anton Knieling, Ancuta Lupu
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Patients with Celiac Disease Have High Prevalence of Fatty Liver and Metabolic Syndrome
    Nishant Aggarwal, Ashish Agarwal, Hasan Alarouri, Vignesh Dwarakanathan, Sana Dang, Vineet Ahuja, Govind K. Makharia
    Digestive Diseases and Sciences.2024; 69(8): 3029.     CrossRef
  • Past, Present, and Future of Noninvasive Tests to Assess Gluten Exposure, Celiac Disease Activity, and End-Organ Damage
    Jocelyn A. Silvester, Luca Elli, Chaitan Khosla, Jason A. Tye-Din
    Gastroenterology.2024; 167(1): 159.     CrossRef
  • The Economic Iceberg of Celiac Disease: More Than the Cost of Gluten-Free Food
    Soran R. Bozorg, Anne R. Lee, Karl Mårild, Joseph A. Murray
    Gastroenterology.2024;[Epub]     CrossRef
  • Gluten-free foods are expensive and nutritionally imbalanced than their gluten-containing counterparts
    Wajiha Mehtab, Samagra Agarwal, Harsh Agarwal, Anam Ahmed, Ashish Agarwal, Shubham Prasad, Ashish Chauhan, Anjali Bhola, Namrata Singh, Vineet Ahuja, Anita Malhotra, Govind K Makharia
    Indian Journal of Gastroenterology.2024; 43(3): 668.     CrossRef
  • Letter: Breaking new ground—Understanding the role of ATI‐free diet in managing MASLD
    Matteo Spertino, Roberta Elisa Rossi, Nicola Pugliese
    Alimentary Pharmacology & Therapeutics.2024; 60(2): 302.     CrossRef
  • Celiac Disease, Gluten-Free Diet and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Georgiana-Diana Cazac, Bogdan-Mircea Mihai, Gabriela Ștefănescu, Georgiana-Emmanuela Gîlcă-Blanariu, Cătălina Mihai, Elena-Daniela Grigorescu, Alina Onofriescu, Cristina-Mihaela Lăcătușu
    Nutrients.2024; 16(13): 2008.     CrossRef
  • Gluten-Free Diet—What’s Good for Celiac Disease Can Be Bad for Metabolism
    Kathleen Viveiros, Sonal Kumar
    Digestive Diseases and Sciences.2024; 69(8): 2721.     CrossRef
  • Influence of a structured, 1-year-long dietary intervention regarding body composition and cardiovascular risk (ARCTIC) in coeliac disease: a protocol of a multicentre randomised controlled trial
    Zsófia Vereczkei, Zsolt Szakács, Míra Zsófia Peresztegi, Klára Lemes, Krisztina Hagymási, Sarolta Dakó, Eszter Dakó, Szilvia Lada, Nándor Faluhelyi, Gábor Szekeres, Gyula Pásztor, Nelli Farkas, Gabriella Pár, Emese Mezősi, Judit Bajor
    BMJ Open.2024; 14(10): e084365.     CrossRef
  • The prevalence of obesity and underweight in celiac patients at the time of diagnosis: a systematic review and meta-analysis
    Farzad Maleki, Marjan Hosseinpour, Ali Delpisheh, Mansour Bahardoust, Fatemeh Hajizadeh-Sharafabad, Mohammad Reza Pashaei
    BMC Gastroenterology.2024;[Epub]     CrossRef
  • Reuse of Almond Skin to Formulate a New Gluten- and Lactose-Free Bakery Product
    Lucia Francesca Vuono, Vincenzo Sicari, Antonio Mincione, Rosa Tundis, Roberta Pino, Natale Badalamenti, Maurizio Bruno, Francesco Sottile, Sonia Piacente, Luca Settanni, Monica Rosa Loizzo
    Foods.2024; 13(23): 3796.     CrossRef
  • Celiac Disease and Liver Damage: The Gut–Liver Axis Strikes Back (Again)? A Retrospective Analysis in the Light of a Literature Review
    Aurelio Seidita, Federica Latteri, Mirco Pistone, Alessandra Giuliano, Luca Bertoncello, Giorgia Cavallo, Marta Chiavetta, Francesco Faraci, Alessia Nigro, Alessandro Termini, Laura Verona, Agnese Ammannato, Salvatore Accomando, Francesca Cavataio, Maria
    Nutrients.2024; 17(1): 85.     CrossRef
  • Gluten: do only celiac patients benefit from its removal from the diet?
    Laryssa Rosa de Sousa Franckilin, Anna Clara Paiva Menezes Dos Santos, Flávio Eduardo Dias Araújo Freitas, Isabela Garbazza Vieira, Carlos Eduardo de Freitas Jorge, Daniela Godoy Neri, Maria Vitória Cota de Abreu, Janaina Koenen Fonseca, Renato Guimarães
    Food Reviews International.2023; 39(7): 4388.     CrossRef
  • Risk of obesity during a gluten-free diet in pediatric and adult patients with celiac disease: a systematic review with meta-analysis
    Michele Barone, Andrea Iannone, Fernanda Cristofori, Vanessa Nadia Dargenio, Flavia Indrio, Elvira Verduci, Alfredo Di Leo, Ruggiero Francavilla
    Nutrition Reviews.2023; 81(3): 252.     CrossRef
  • Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
    Mihaela Simona Popoviciu, Nirja Kaka, Yashendra Sethi, Neil Patel, Hitesh Chopra, Simona Cavalu
    Journal of Personalized Medicine.2023; 13(3): 422.     CrossRef
  • Celiac Disease and Cardiovascular Risk: A Retrospective Case-Control Study
    Maria Pina Dore, Sandro Mereu, Pier Sergio Saba, Michele Portoghese, Giovanni Mario Pes
    Journal of Clinical Medicine.2023; 12(6): 2087.     CrossRef
  • Nutritional status, nutrient imbalances, food-related behaviors and dietary supplements use among patients with celiac disease on a gluten free diet in Lebanon: a national cross-sectional study
    Maha Hoteit, Zeinab Chamas, Shaza Assaf, Malek Michael Bouhairie, Abbas Bahr, Romy Daccache, Rami Matar, Mahmoud Hallal, Samer Hotayt, Bilal Hotayt
    F1000Research.2023; 11: 725.     CrossRef
  • Fatty liver and celiac disease: Why worry?
    Janaina Luz Narciso-Schiavon, Leonardo Lucca Schiavon
    World Journal of Hepatology.2023; 15(5): 666.     CrossRef
  • Prevalence of autoimmune, cholestatic and nonalcoholic fatty liver disease in celiac disease
    Asif Ali Hitawala, Ashraf Almomani, Somtochukwu Onwuzo, Antoine Boustany, Prabhat Kumar, Imad Asaad
    European Journal of Gastroenterology & Hepatology.2023; 35(9): 1030.     CrossRef
  • Body Mass Index during Gluten-Free Diet in Patients with Celiac Disease
    Zsófia Vereczkei, Tímea Dergez, Zsuzsanna Fodor, Zsolt Szakács, Judit Bajor
    Nutrients.2023; 15(16): 3517.     CrossRef
  • Obesity and Colorectal Cancer
    Jundeok Lee, Su Young Kim
    The Korean Journal of Gastroenterology.2023; 82(2): 63.     CrossRef
  • Incidentally Discovered Cryptogenic Cirrhosis in a Patient with Untreated Celiac Disease
    Kelli Kosako Yost, Yasmin Alishahi
    Galician Medical Journal.2023; 30(3): E202336.     CrossRef
  • The association of interleukin-10 single nucleotide polymorphisms (rs1800871) and serum levels in Iraqi patients with celiac disease: A case-control study
    Ali Hafedh Abbas, Sahar Taha Hatif, Faiq Isho Gorial, Sara Bayan Ali
    Clinical Epidemiology and Global Health.2023; 24: 101437.     CrossRef
  • Unveiling the Link: A Comprehensive Narrative Review of the Relationship Between Type 1 Diabetes Mellitus and Celiac Disease
    Sanvi Arora, Ayush Tayade, Tanya Bhardwaj, Swanand S Pathak
    Cureus.2023;[Epub]     CrossRef
  • Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis
    Shalimar, Anshuman Elhence, Bhavik Bansal, Hardik Gupta, Abhinav Anand, Thakur P. Singh, Amit Goel
    Journal of Clinical and Experimental Hepatology.2022; 12(3): 818.     CrossRef
  • Nutritional status, nutrient imbalances, food-related behaviors and dietary supplements use among patients with celiac disease in Lebanon: a national cross-sectional study
    Maha Hoteit, Zeinab Chamas, Shaza Assaf, Malek Michael Bouhairie, Abbas Bahr, Romy Daccache, Rami Matar, Marwa Hallal, Michael Maitar, Mahmoud Hallal, Samer Hotayt, Bilal Hotayt
    F1000Research.2022; 11: 725.     CrossRef
  • Eating Competence and Aspects Related to a Gluten-Free Diet in Brazilian Adults with Gluten-Related Disorders
    Pâmela Mayara de Oliveira, Renata Puppin Zandonadi, Amanda Moreira Veloso Cutrim, Eduardo Yoshio Nakano, Fabiana Lopes Nalon de Queiroz, Raquel B. A. Botelho, Ariana Saraiva, António Raposo
    Nutrients.2022; 14(14): 2815.     CrossRef
  • Nutritional status, nutrient imbalances, food-related behaviors and dietary supplements use among patients with celiac disease on a gluten free diet in Lebanon: a national cross-sectional study
    Maha Hoteit, Zeinab Chamas, Shaza Assaf, Malek Michael Bouhairie, Abbas Bahr, Romy Daccache, Rami Matar, Marwa Hallal, Mahmoud Hallal, Samer Hotayt, Bilal Hotayt
    F1000Research.2022; 11: 725.     CrossRef
  • Multidimensional Disadvantages of a Gluten-Free Diet in Celiac Disease: A Narrative Review
    Martyna Marciniak, Aleksandra Szymczak-Tomczak, Dagmara Mahadea, Piotr Eder, Agnieszka Dobrowolska, Iwona Krela-Kaźmierczak
    Nutrients.2021; 13(2): 643.     CrossRef
  • The Healthy Gluten-Free Diet: Practical Tips to Prevent Metabolic Disorders and Nutritional Deficiencies in Celiac Patients
    Emanuele Rinninella, Marco Cintoni, Pauline Raoul, Silvia Triarico, Tommaso Dionisi, Giovanni Battista Gasbarrini, Antonio Gasbarrini, Maria Cristina Mele
    Gastroenterology Insights.2021; 12(2): 166.     CrossRef
  • Nutritional Properties of Rice Varieties Commonly Consumed in Italy and Applicability in Gluten Free Diet
    Giorgia Vici, Diego Romano Perinelli, Dalia Camilletti, Flora Carotenuto, Luca Belli, Valeria Polzonetti
    Foods.2021; 10(6): 1375.     CrossRef
  • Physical development in children with celiac disease in St. Petersburg
    N. S. Shapovalova, V. P. Novikova, K. A. Klikunova
    Experimental and Clinical Gastroenterology.2021; (4): 116.     CrossRef
  • Celiac disease and obesity: the possibility of comboridity of pathology in children
    V. P. Novikova, V. L. Gritsinskaya, A. I. Khavkin
    Experimental and Clinical Gastroenterology.2021; (4): 124.     CrossRef
  • 16,034 View
  • 249 Download
  • 44 Web of Science
  • 52 Crossref
Close layer
IBD
What nutritional factors influence bone mineral density in Crohn's disease patients?
Fernanda Gomes Coqueiro, Raquel Rocha, Camilla Almeida Menezes, Mirella Brasil Lopes, Vanessa Rosa Oliveira, Flora Maria Lorenzo Fortes, Genoile Oliveira Santana
Intest Res 2018;16(3):436-444.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.436
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Bone mineral density (BMD) is often low in patients with Crohn's disease (CD). This study aimed to evaluate the association between nutritional factors and BMD in a group of CD patients.

Methods

CD patients 18 years of age or older were included. The body mass index (BMI), waist circumference (WC) and dietary intake were evaluated during two 24-hour recalls. Bone densitometry was performed by dual-energy X-ray absorptiometry of the full body to assess body composition and of the lumbar vertebrae and femoral neck to assess BMD.

Results

In the 60 patients evaluated, there was no association between BMD and disease activity or between BMD and disease duration. We observed moderate correlations between BMD in at least one of the evaluated sites and BMI, lean mass, WC, and protein, calcium, phosphorus and magnesium dietary intakes (P<0.05). In the linear regression analysis for spinal BMD, only BMI and calcium dietary intake remained associated (P<0.05). In the linear regression analysis for femoral BMD, WC and phosphorus intake continued to be significant in the final model, although they had low explanatory power for BMD (P<0.05).

Conclusions

The prevalence of low BMD was high in CD patients. BMI, WC, calcium and phosphorus dietary intake were positively correlated with BMD.

Citations

Citations to this article as recorded by  
  • Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel disease
    Shilpa Sharma
    Intestinal Research.2025; 23(3): 254.     CrossRef
  • White matter free water and depressive symptoms in medication-free depressed adolescents: moderation by peripheral inflammation
    Weicheng Li, Zerui You, Chengyu Wang, Xiaofeng Lan, Fan Zhang, Zhibo Hu, Xiaoyu Chen, Zhanjie Luo, Yexian Zeng, Yiying Chen, Yifang Chen, Siming Mai, Robin Shao, Hanna Lu, Roger S. McIntyre, Xiangdong Sun, Yuping Ning, Yanling Zhou
    Translational Psychiatry.2025;[Epub]     CrossRef
  • The Effect of Protein Nutritional Support on Inflammatory Bowel Disease and Its Potential Mechanisms
    Qingye Li, Jing Wang
    Nutrients.2024; 16(14): 2302.     CrossRef
  • Assessment of dietary nutrient intake and its relationship to the nutritional status of patients with Crohn’s Disease in Guangdong Province of China
    Hong Zheng, Xinbin Chen, Xiaoling Bu, Xia Qiu, Demeng Zhang, Yitong Zhou, Junlong Lin, Jinghong Li, Wenjun Ma, Ying Zheng
    Nutrición Hospitalaria.2023;[Epub]     CrossRef
  • Serum N-terminal telopeptide of type I collagen as a biomarker for predicting bone density loss in patients with Crohn disease
    Natsuki Ishida, Tomohiro Higuchi, Takahiro Miyazu, Satoshi Tamura, Satoshi Suzuki, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto, Mathilde Body-Malapel
    PLOS ONE.2021; 16(4): e0250658.     CrossRef
  • Osteoporosis Complications in Crohn's Disease Patients: Factors, Pathogenesis, and Treatment Outlines
    Yaqot N Baban, Christopher M Edicheria, Joseph Joseph, Parneet Kaur, Jihan A Mostafa
    Cureus.2021;[Epub]     CrossRef
  • Crohn Disease and Fracture Risk Assessment With FRAX
    Grethe B Jonasson, Jack Hilon, Bengt Hasseus, Torgny Alstad, Hossein Kashani
    Crohn's & Colitis 360.2019;[Epub]     CrossRef
  • 8,405 View
  • 78 Download
  • 7 Web of Science
  • 7 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP